Capital increase of euro 140 million to support the new 2022 – 2024 strategic business plan
Investment agreement signed with CDP Equity
The goals that Gpi intends to achieve through the implementation of the new Plan are:
- to consolidate and increase the Company’s presence in the domestic market through the development of an offering that responds to innovation in care models through digital transformation and through a people-centred focus;
- to gain leadership in Virtual Care (telemedicine), enhancing the approach that places the patient at the centre, through a proposition of solutions that enable the secure management of health data, paying particular attention to cybersecurity, in line with the strategic priorities of the NRRP;
- to strengthen Gpi’s positioning internationally, particularly on the European and American continents, with primary focus in transfusion and drug automation;
- to continue to invest in innovation to anticipate new product solutions in an ever-changing market, to be distinctive from competitors, also leveraging artificial intelligence to make Gpi solutions predictive and decision-supportive
The plan is to achieve revenues of more than euro 500 mln in 2024 (CAGR 21-24 >15%), including at least euro 420 mln in organic revenues and at least euro 80 mln in growth through external lines, with an EBITDA margin of more than 17%.
